Erkka Valovirta
- Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence (2020)
- Journal of Allergy and Clinical Immunology
- Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials (2020)
- Journal of Allergy and Clinical Immunology: In Practice
- Siedätyshoidon haittavaikutukset (2020) Allergiset sairaudet ja astma Erkka Valovirta, Johannes Savolainen
- Siedätyshoidon periaatteet (2020) Allergiset sairaudet ja astma Erkka Valovirta, Johannes Savolainen, Pia Ralli
- Siedätyshoidon potilasohjaus (2020) Allergiset sairaudet ja astma Tanja Utriainen, Pia Ralli, Erkka Valovirta, Johannes Savolainen
- Siedätyshoidon toteutus (2020) Allergiset sairaudet ja astma Erkka Valovirta, Johannes Savolainen
- Siedätyshoidon varotoimet (2020) Allergiset sairaudet ja astma Erkka Valovirta, Johannes Savolainen
- Siedätyshoidon vasta-aineet (2020) Allergiset sairaudet ja astma Erkka Valovirta, Johannes Savolainen
- Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study (2020)
- Clinical and Translational Allergy
- 2019 ARIA Care pathways for allergen immunotherapy (2019)
- Allergy
- Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study (2019)
- Clinical and Experimental Allergy
- Allergian ihopistokokeiden perussarja on aika yhtenäistää (2019)
- Lääkärilehti
- Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019)
- Journal of Allergy and Clinical Immunology
- ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy" (2019)
- Allergy
- ARIA-Versorgungspfade für die Allergenimmuntherapie 2019 (2019)
- Allergologie
- Birch pollen allergy in Europe (2019)
- Allergy
- Contraindications to immunotherapy: a global approach (2019)
- Clinical and Translational Allergy
- Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: a 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension (2019)
- Clinical and Experimental Allergy
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019)
- Clinical and Translational Allergy
- Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study (2019)
- Journal of Allergy and Clinical Immunology



